During the last session, 180 Life Sciences Corp. (NASDAQ:ATNF)’s traded shares were 1,878,311, with the beta value of the company hitting -0.72. At the end of the trading day, the stock’s price was $7.93, reflecting an intraday gain of 12.01% or $0.85. The 52-week high for the ATNF share is $11.5, that puts it down -45.02% from that peak though still a striking +76.04% gain since the share price plummeted to a 52-week low of $1.9. The company’s market capitalization is $190.9 Million, and the average intraday trading volume over the past 10 days was 1.35 Million shares, and the average trade volume was 2.24 Million shares over the past three months.
180 Life Sciences Corp. (ATNF) received a consensus recommendation of 0 from analysts. That translates to a mean rating of 0. ATNF has a Sell rating from none of the analyst(s) out of 0 analysts who have looked at this stock. Neither of the analyst(s) recommend to Hold the stock while none of them suggest Overweight, and no one recommend a Buy rating for it. None of the analyst(s) has rated the stock Underweight.
180 Life Sciences Corp. (NASDAQ:ATNF): Trading Information
180 Life Sciences Corp. (ATNF) registered a 12.01% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 4.46% in intraday trading to $8.30- this Wednesday, Apr 07, hitting a weekly high. The stock’s 5-day price performance is 29.15%, and it has moved by 96.77% in 30 days. Based on these gigs, the overall price performance for the year is 190.48%. The short interest in 180 Life Sciences Corp. (NASDAQ:ATNF) is 2.27 Million shares and it means that shorts have 1.01 day(s) to cover.
180 Life Sciences Corp. (ATNF) projections and forecasts
An analysis of the company’s performance over the past 5 years shows that the company’s earnings fell an estimated 0%. While earnings are projected to return -130.9% in 2021, the next five years will return 0% per annum.